3,4‐Di‐2‐pyridyl‐1,2,5‐oxadiazole and its perchlorate salt

In 3,4‐di‐2‐pyridyl‐1,2,5‐oxadiazole (dpo), C₁₂H₈N₄O, each mol­ecule resides on a twofold axis and inter­acts with eight neighbours via four C—H⋯N and four C—H⋯O inter­actions to generate a three‐dimensional hydrogen‐bonded architecture. In the perchlorate analogue, 2‐[3‐(2‐pyrid­yl)‐1,2,5‐oxadiazol‐4‐yl]pyridinium perchlorate, C₁₂H₉N₄O⁺·ClO₄⁻ or [Hdpo]ClO₄, the [Hdpo]⁺ cation is bisected by a crystallographic mirror plane, and the additional H atom in the cation is shared by the two pyridyl N atoms to form a symmetrical intra­molecular N⋯H⋯N hydrogen bond. The cations and perchlorate anions are linked through C—H⋯O hydrogen bonds and π–π stacking inter­actions to form one‐dimensional tubes along the b‐axis direction.     

Tetra­aqua­(7‐hydroxy‐5‐oxidoflavone‐6‐sulfonato‐κ2O4,O5)nickel(II) dimethyl­formamide solvate monohydrate

In the title compound, [Ni(C₁₅H₈O₇S)(H₂O)₄]·C₃H₇NO·H₂O, the Ni^II cation is chelated by a 7‐hydroxy‐5‐oxidoflavone‐6‐sulfonate ligand through one oxide and one carbonyl O atom, and the sixfold coordination is completed by four aqua ligands. Individual mol­ecules are linked into hydrogen‐bonded dimers by way of five pairs of O—H⋯O hydrogen bonds. These dimers, in turn, determine a three‐dimensional supra­molecular arrangement through a variety of inter­dimeric inter­actions, such as O—H⋯O, C—H⋯O and π–π stacking.     

(R)‐N‐[(R)‐1‐(2‐Hydroxy‐5‐methyl­phenyl)‐2‐phenyl­ethyl]‐2‐methyl‐1‐phenyl­propyl­ammonium chloride

In the title compound, C₂₅H₃₀NO⁺·Cl⁻, the mol­ecules are linked by a combination of inter­molecular N—H⋯Cl and O—H⋯Cl hydrogen bonds and intra­molecular N—H⋯O hydrogen bonds. The absolute configuration of the new stereogenic centre (the C atom adjacent to the N atom on the phenol side) is determined to have an R configuration.     

(Glycylglycinato‐κ3O,N,N′)(2‐methyl‐1H‐benzimidazole‐κN3)copper(II) trihydrate

In the title compound, [Cu(C₄H₆N₂O₃)(C₈H₈N₂)]·3H₂O, the Cu^II atom is coordinated in a square‐planar manner by one O atom and three N atoms from glycylglycinate and 2‐methyl­benzimidazole ligands. The ternary complexes assemble into one‐dimensional chains through C—H⋯π inter­actions and direct N—H⋯O hydrogen bonding, as well as into hydrogen‐bonded water helices with branches which also link the complex chains into a three‐dimensional supra­molecular structure.     

Bis(μ‐acetato)(μ‐2,6‐bis­{[(2‐hydroxy­ethyl)(2‐pyridylmeth­yl)amino]meth­yl}‐4‐methyl­phenolato)dinickel(II) hexa­fluoro­phosphate hemihydrate

The asymmetric unit of the title compound, [Ni₂(C₂₅H₃₁N₄O₃)(C₂H₃O₂)₂]PF₆·0.5H₂O, consists of two dinuclear nickel cations, two hexa­fluoro­phosphate anions and one water mol­ecule of crystallization. Within each cation, the Ni atoms are bridged by two exogenous acetate groups and an endogenous cresol O atom of a phenolate‐based `end‐off' compartmental ligand that possesses two pendant chelating arms attached to the ortho positions of the phenol ring. Each Ni atom is six‐coordinate with a slightly distorted octa­hedral geometry. The two symmetry‐independent cations are linked into a dimeric unit through O—H⋯O hydrogen bonds. Additional O—H⋯O, C—H⋯F and C—H⋯O inter­molecular inter­actions link all of the units in the structure into a three‐dimensional framework.     

1‐((E)‐{(1R,2R)‐2‐[(E)‐(2‐Hydr­oxy‐1‐naphth­yl)methyl­eneamino]cyclo­hexyl}iminiometh­yl)naphthalen‐2‐olate: a Schiff base compound having both OH and NH character

The title Schiff base compound, C₂₈H₂₆N₂O₂, possesses both OH and NH tautomeric character in its mol­ecular structure. While the OH side of the compound is described as an inter­mediate state, its NH side adopts a predominantly zwitterionic form. The mol­ecular structure of the compound is stabilized by both N⁺—H⋯O⁻ and O—H⋯N intra­molecular hydrogen bonds. There are two weak C—H⋯O hydrogen bonds leading to polymeric chains of topology C(5) and C(13) running along the b axis of the unit cell. In addition, inter­molecular C—H⋯π inter­actions serve to stabilize the extended structure.     

Dichloro­{2‐[2‐(dimethyl­ammonio)­ethyl­imino­meth­yl]‐4‐nitro­phenolato}­zinc(II) in unsolvated and hemihydrate forms

The two title complexes, [ZnCl₂(C₁₁H₁₅N₃O₃)], (I), and [ZnCl₂(C₁₁H₁₅N₃O₃)]·0.5H₂O, (II), are mononuclear zinc(II) compounds. In both structures, the Zn^II atom is four‐coordinated in a tetra­hedral configuration by one imine N atom and one phenolate O atom of a Schiff base, and by two Cl atoms. The structure of each of the two zinc(II) complex molecules of (II) is similar to that of (I). In (I), the mol­ecules are linked through inter­molecular hydrogen bonds, forming a three‐dimensional framework. In (II), the solvent water mol­ecules are linked to the zinc(II) moieties through inter­molecular O—H⋯O and O—H⋯Cl hydrogen bonds. The mol­ecules in (II) are further linked via other inter­molecular hydrogen bonds, forming a three‐dimensional framework.     

Hydrogen bonding in meso‐4,5‐diphenyl‐3,6‐diaza­octane‐1,8‐diol: the formation of one‐dimensional linear chains of edge‐fused rings

The molecule of the title compound, C₁₈H₂₄N₂O₂, resides on a crystallographic inversion centre. The mol­ecule adopts a transoid conformation with respect to the central C—C single bond and is in the meso form. A polarimetric study of the compound did not show any optical activity, indicating that the compound is a racemic mixture entirely consistent with the centrosymmetric space group. In the mol­ecule, there is one intra­molecular N—H⋯O inter­action, resulting in the formation of a five‐membered ring. In the crystal structure, inter­molecular O—H⋯N and C—H⋯O inter­actions are also observed. These inter­actions form an R₂²(9) ring and one‐dimensional linear chains of edge‐fused rings running parallel to the [010] direction, which stabilize the crystal packing.     

catena‐Poly­[[(di‐2‐pyridyl­amine)­silver(I)]‐μ‐nicotinato] and catena‐poly­[[(di‐2‐pyridyl­amine)silver(I)]‐μ‐2,6‐di­hydroxy­benzoato]

In catena‐poly­[[(di‐2‐pyridyl­amine‐κ²N,N′)silver(I)]‐μ‐nico­tinato‐κ²N:O], [Ag(C₆H₄NO₂)(C₁₀H₉N₃)]_n, the Ag^I atom is tetracoordinated by two N atoms from the di‐2‐pyridyl­amine (BPA) ligand [Ag—N = 2.3785 (18) and 2.3298 (18) Å] and by one N atom and one carboxyl­ate O atom from nicotinate ligands [Ag—N = 2.2827 (15) Å and Ag—O = 2.3636 (14) Å]. Bridging by nicotinate N and O atoms generates a polymeric chain structure, which extends along [100]. The carboxyl O atom not bonded to the Ag atom takes part in an intrachain C—H⋯O hydrogen bond, further stabilizing the chain. Pairs of chains are linked by N—H⋯O hydrogen bonds to generate ribbons. There are no π–π interactions in this complex. In catena‐poly­[[(di‐2‐pyridyl­amine‐κ²N,N′)silver(I)]‐μ‐2,6‐di­hydroxy­benzoato‐κ²O¹:O²], [Ag(C₇H₅O₄)(C₁₀H₉N₃)]_n, the Ag^I atom has a distorted tetrahedral coordination, with three strong bonds to two pyridine N atoms from the BPA ligand [Ag—N = 2.286 (5) and 2.320 (5) Å] and to one carboxyl­ate O atom from the 2,6‐di­hydroxy­benzoate ligand [Ag—O = 2.222 (4) Å]; the fourth, weaker, Ag‐atom coordination is to one of the phenol O atoms [Ag⋯O = 2.703 (4) Å] of an adjacent moiety, and this interaction generates a polymeric chain along [100]. Pairs of chains are linked about inversion centers by N—H⋯O hydrogen bonds to form ribbons, within which there are π–π interactions. The ribbons are linked about inversion centers by pairs of C—H⋯O hydrogen bonds and additional π–π interactions between inversion‐related pairs of 2,6‐di­hydroxy­benzoate ligands to generate a three‐dimensional network.     

{μ‐N,N′‐Bis[3‐(dimethyl­amino)prop­yl]­oxamidato(2–)‐κ6N,N′,O′:N′′,N′′′,O}­bis­[(1H‐imidazole‐κN3)(methanol‐κO)copper(II)] bis­(perchlorate)

The structure of the title compound, [Cu₂(C₁₂H₂₄N₄O₂)(C₃H₄N₂)₂(CH₄O)₂](ClO₄)₂ or [Cu₂(dmoxpn)(HIm)₂(CH₃OH)₂](ClO₄)₂, where dmoxpn is the dianion of N,N′‐bis­[3‐(dimethyl­amino)prop­yl]oxamide and HIm is imidazole, consists of a centrosymmetric trans‐oxamidate‐bridged copper(II) binuclear cation, having an inversion centre at the mid‐point of the central C—C bond, and two perchlorate anions. The Cu^II atom has square‐pyramidal coordination geometry involving two N atoms and an O atom from the dmoxpn ligand, an N atom from an imidazole ring, and an O atom from a methanol mol­ecule. The crystal structure is stabilized by O—H⋯O, N—H⋯O and C—H⋯O hydrogen bonds and imidazole π–π stacking inter­actions to form a three‐dimensional supra­molecular array.     

4‐(4‐Fluoro‐3‐phenoxy­phen­yl)‐6‐(4‐fluoro­phen­yl)‐2‐oxo‐1,2‐dihydro­pyridine‐3‐carbonitrile and the 6‐(4‐methyl­phen­yl)‐ analogue

The crystal structures of the title compounds, viz. C₂₄H₁₄F₂N₂O₂, (I), and C₂₅H₁₇FN₂O₂, (II), respectively, have been determined in order to unravel the role of an ordered F atom in generating stable supra­molecular assemblies. On changing the substitution from fluorine to a methyl group, C—H⋯F inter­actions are replaced by C—H⋯π inter­actions, revealing the importance of such weak inter­actions when present alongside N—H⋯O and C—H⋯O hydrogen bonds. The dihedral angle between the planes of the 4‐fluoro­phenyl ring and the pyridine ring is 26.8 (1)° in (I), while that between the planes of the 4‐methyl­phenyl and pyridine rings is 29.5 (1)° in (II).     

3,3a‐Dihydrocyclo­penta­[b]­chromen‐1(2H)‐ones from the reaction of salicylaldehyde and 2‐cyclo­penten‐1‐one

The two title chromene compounds, 3,3a‐dihydrocyclo­penta­[b]chromen‐1(2H)‐one, C₁₆H₁₂O₂, (I), and 2‐(2‐hydroxy­benzyl­idene)‐3,3a‐dihydrocyclo­penta­[b]chromen‐1(2H)‐one, C₁₉H₁₄O₃, (II), have been determined in the monoclinic space group P2₁/n. Compound (I) is mainly stabilized by C—H⋯π inter­actions. Compound (II) is linked into infinite one‐dimensional chains with a C(3) motif via inter­molecular O—H⋯O hydrogen bonds. The inter­molecular C—H⋯π and π–­π inter­actions also play key roles in stabilizing the crystal packing. Two intra­molecular C—H⋯O hydrogen bonds with S(5) motifs were detected in (II).     

[Di‐2‐pyridyl ketone N4,N4‐(butane‐1,4‐di­yl)­thio­semi­carbazonato‐κ3N,N′,S]­di­oxo­vanadium(V)

The V^V atom in the title complex, [V(C₁₆H₁₆N₅S)O₂], is five‐coordinate in a highly distorted square‐pyramidal geometry, with the pyridyl N, the azomethine N and the thiol­ate S atoms of the di‐2‐pyridyl ketone N⁴,N⁴‐(butane‐1,4‐di­yl)­thio­semi­carbazone ligand and one oxo ligand occupying the basal coordination positions, while the second oxo ligand occupies the apical position. The mol­ecules are inter­connected by weak inter­molecular inter­actions, mainly of the C—H⋯O type, involving the oxo atoms.     

N‐(2,4‐Dimethoxy­benzyl­idene­amino)­guanidinium dihydrogenphosphate

In the asymmetric unit of the title compound, C₁₀H₁₅N₄O₂⁺·H₂PO₄⁻, there are two protonated amino­guanidinium cations and two dihydrogenphosphate anions. The positive charge on the protonated amidine group is delocalized over the three C—N bonds in a manner similar to that found in guanidinium salts. The amino­guanidinium cations are found to be the E‐isomer structures. Intra­molecular inter­actions of the N—H⋯N type are observed, leading to the formation of five‐membered rings. Extensive networks of O—H⋯O, N—H⋯O and C—H⋯O hydrogen bonds stabilize the three‐dimensional network. In the crystal structure, π–π inter­actions between the benzene rings, with a distance of 3.778 (2) Å between the ring centroids, also affect the packing of the mol­ecules.     

mer‐Di­aqua­bis(1H‐imidazole‐κN3)(orotato‐κ2N3,O4)­nickel(II)

The title mononuclear complex, [Ni(C₅H₂N₂O₄)(C₃H₄N₂)₂(H₂O)₂] or [Ni(HOr)(im)₂(H₂O)₂] (im is imidazole and H₃Or is orotic acid, or 2,6‐dioxo‐1,2,3,6‐tetra­hydro­pyrimidine‐4‐carboxylic acid), has been synthesized and the crystal structure determination is reported. The Ni^II ion in the complex has a distorted octahedral coordination geometry comprised of one deprotonated pyrimidine N atom and the adjacent carboxyl­ate O atom of the orotate ligand, two tertiary imidazole N atoms and two aqua ligands. An extensive three‐dimensional network of OW—H⋯O and N—H⋯O hydrogen bonds, and π–π and π–ring interactions are responsible for crystal stabilization.     

Dichloro­(O‐ethyl 3‐methyl­pyridine‐2‐carboximidic acid‐κ2N,N′)copper(II)

In the title compound, [CuCl₂(C₉H₁₂N₂O)], the Cu^II atom is coordinated by two Cl⁻ anions and two N atoms of one O‐ethyl 3‐methyl­pyridine‐2‐carboximidic acid mol­ecule in a slightly distorted square‐planar geometry, with Cu—N distances of 2.0483 (17) and 1.9404 (18) Å, and Cu—Cl distances of 2.2805 (10) and 2.2275 (14) Å. In addition, each Cu^II atom is connected by one Cl⁻ anion and the Cu^II atom from a neighbouring mol­ecule, with Cu⋯Cl and Cu⋯Cu distances of 2.9098 (13) and 3.4022 (12) Å, respectively, and, therefore, a centrosymmetric dimer is formed. Adjacent mol­ecular dimers are connected by π–π stacking inter­actions between pyridine rings to form a zigzag mol­ecular chain. The mol­ecular chains are also enforced by N—H⋯Cl and C—H⋯Cl inter­actions.     

catena‐Poly[[{4‐bromo‐2‐[2‐(di­methyl­amino)­ethyl­imino­meth­yl]­phenolato}­copper(II)]‐μ‐thio­cyanato]

The title complex, [Cu(C₁₁H₁₄BrN₂O)(NCS)]_n, is an inter­esting thio­cyanate‐bridged polynuclear copper(II) compound, which crystallizes with two independent mol­ecules in the asymmetric unit. Each Cu^II atom is five‐coordinate in a square‐pyramidal configuration, with one O and two N atoms of one Schiff base ligand and one terminal N atom of a bridging thio­cyanate ligand defining the basal plane, and one terminal S atom of another bridging thio­cyanate ligand occupying the apical position. The {4‐bromo‐2‐[2‐(dimethyl­amino)ethyl­imino­meth­yl]phenolato}copper(II) units are linked by the bridging thio­cyanate ligands, forming polymeric chains running along the a axis. There are weak inter­molecular C—H⋯O and C—H⋯S hydrogen bonds between the chains in the crystal structure.     

catena‐Poly[[[diaqua­bis(pyridine‐4‐carboxamide‐κN)copper(II)]‐μ2‐squarato‐κO1:O3] dihydrate]

The asymmetric unit of the title compound, {[Cu(C₄O₄)(C₆H₆N₂O)₂(H₂O)₂]·2H₂O}_n, consists of one pyridine‐4‐carbox­amide (isonicotinamide or ina) ligand, one‐half of a squarate dianion, a coordinated aqua ligand and a solvent water mol­ecule. Both the Cu^II and the squarate ions are located on inversion centers. The Cu^II ions are octa­hedrally surrounded by four O atoms of two water mol­ecules and two squarate anions, and by two N atoms of the isonicotinamide ligands. The crystal structure contains chains of squarate‐1,3‐bridged Cu^II ions. These chains are held together by N—H⋯O and O—H⋯O inter­molecular hydrogen‐bond inter­actions, forming an extensive three‐dimensional network.     

(2S,RS)‐6‐Phenyl‐1‐(p‐tolyl­sulfinyl)­hexa‐3(E),5(E)‐dien‐2‐ol

The mol­ecule of the title compound, C₁₉H₂₀O₂S, corresponds to a chiral sulfinyldienol with two stereogenic centres, viz. the C atom susbtituted by the hydr­oxy group and the sulfinyl S atom. The mol­ecule displays a V‐shape in the solid state. The dihedral angle defined by the least‐squares planes of the aromatic rings is 72.9 (1)°. The packing pattern exhibits the following inter­molecular hydrogen bonds: one O—H⋯O [H⋯O = 1.98 Å, O⋯O = 2.785 (4) Å and O—H⋯O = 166°] and two C—H⋯O [H⋯O = 2.58 and 2.60 Å, C⋯O = 3.527 (5) and 3.347 (5) Å, and C—H⋯O = 164 and 134°]. These define a chain along b.     

4,4′‐Butane‐1,4‐diylbis[3‐ethyl‐1H‐1,2,4‐triazol‐5(4H)‐one] and 4‐hydr­oxy‐3‐n‐prop­yl‐1H‐1,2,4‐triazol‐5(4H)‐one

The title compounds, C₁₂H₂₀N₆O₂, (I), and C₅H₉N₃O₂, (II), display the characteristic features of 1,2,4‐triazole derivatives. Compound (I) lies about an inversion centre which is at the mid‐point of the central C—C bond. Compound (II) also contains a planar 1,2,4‐triazole ring but differs from (I) in that it has a hydr­oxy group attached to the ring. Mol­ecules of (I) are held together in the crystal structure by inter­molecular N—H⋯O contacts and by weak π–π stacking inter­actions between the 1,2,4‐triazole moieties. Compound (II) contains inter­molecular O—H⋯O and N—H⋯O hydrogen bonds.